BR9916795A - Cristais de 5-{{6-( 2-fluorobenzil) oxi-2- naftil} metil} -2,4- tiazolidinodiona - Google Patents
Cristais de 5-{{6-( 2-fluorobenzil) oxi-2- naftil} metil} -2,4- tiazolidinodionaInfo
- Publication number
- BR9916795A BR9916795A BR9916795-6A BR9916795A BR9916795A BR 9916795 A BR9916795 A BR 9916795A BR 9916795 A BR9916795 A BR 9916795A BR 9916795 A BR9916795 A BR 9916795A
- Authority
- BR
- Brazil
- Prior art keywords
- sym
- crystals
- thiazolidinedione
- fluorobenzyl
- oxy
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 5
- PKWDZWYVIHVNKS-UHFFFAOYSA-N netoglitazone Chemical compound FC1=CC=CC=C1COC1=CC=C(C=C(CC2C(NC(=O)S2)=O)C=C2)C2=C1 PKWDZWYVIHVNKS-UHFFFAOYSA-N 0.000 title abstract 2
- WHUBKNDNRSGZIS-UHFFFAOYSA-N 1-(2-fluorophenyl)-2-phenylethane-1,2-dione Chemical compound FC1=CC=CC=C1C(=O)C(=O)C1=CC=CC=C1 WHUBKNDNRSGZIS-UHFFFAOYSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cosmetics (AREA)
Abstract
Patente de Invenção "CRISTAIS DE 5[{6 (2-(2-FLUOROBENZIL) OXI- 2-NAFTIL}METIL]-2,4-TIAZOLIDINODIONA". A presente invenção refere-se ao cristal do tipo A de 5-[{6-(2-fluorobenzil)oxi-2-naftil}metil]-2,4-tiazolidinodiona, caracterizado pelo fato de que possui picos de absorção característicos (2<sym>) a 11,5<198> <sym> 0,3<198>, 14,5<198> <sym> 0,2<198>, 16,2<198> <sym> 0,3<sym>, 17,0<sym> <sym> 0,3<sym>, 17,7<sym> <sym> 0,2<sym>, 18,6<sym> <sym> 0,3<sym>, 19,1<sym> <sym> 0,2<sym>, 21,3<sym> <sym> 0,4<sym>, 22,4<sym> <sym> 0,5<sym>, 25,7<sym> <sym> 0,5<sym> e 28,3<sym> <sym> 0,5<sym> em padrão de difração de raio X de pó, bem como um método de sua preparação e uma composição farmacêutica que as compreende. O cristal apresenta excelente estabilidade e possui vantagens de manuseio, armazenagem e preparação farmacêutica. A presente invenção também se refere a cristais do tipo B, C e D do mencionado composto.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33054698 | 1998-11-20 | ||
| PCT/JP1999/006492 WO2000031055A1 (en) | 1998-11-20 | 1999-11-19 | Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9916795A true BR9916795A (pt) | 2002-04-09 |
Family
ID=18233859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9916795-6A BR9916795A (pt) | 1998-11-20 | 1999-11-19 | Cristais de 5-{{6-( 2-fluorobenzil) oxi-2- naftil} metil} -2,4- tiazolidinodiona |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US6541493B1 (pt) |
| EP (1) | EP1131310B1 (pt) |
| JP (1) | JP3784001B2 (pt) |
| KR (1) | KR100652326B1 (pt) |
| CN (1) | CN1326449A (pt) |
| AT (1) | ATE315552T1 (pt) |
| AU (1) | AU1185100A (pt) |
| BR (1) | BR9916795A (pt) |
| CA (1) | CA2351727C (pt) |
| CZ (1) | CZ20011763A3 (pt) |
| DE (1) | DE69929476T2 (pt) |
| ES (1) | ES2257104T3 (pt) |
| HU (1) | HUP0104139A3 (pt) |
| ID (1) | ID30064A (pt) |
| IL (1) | IL143177A0 (pt) |
| NO (1) | NO20012444L (pt) |
| NZ (1) | NZ512429A (pt) |
| PL (1) | PL348502A1 (pt) |
| PT (1) | PT1131310E (pt) |
| TR (4) | TR200101901T2 (pt) |
| TW (2) | TWI250156B (pt) |
| WO (1) | WO2000031055A1 (pt) |
| ZA (1) | ZA200104081B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1131310E (pt) * | 1998-11-20 | 2006-05-31 | Mitsubishi Chem Corp | Cristais de 5-[{6-(2-fluorobenzil)oxi-2-naftil}metil]-2,4-tiazolidinadiona |
| JP2003514807A (ja) * | 1999-11-19 | 2003-04-22 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 固態形の５−［［６−［（２−フルオロフェニル）メトキシ］−２−ナフタレニル］メチル］−２，４−チアゾリジンジオン |
| JP4590159B2 (ja) * | 2001-04-04 | 2010-12-01 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | グルコース再吸収阻害剤およびｐｐａｒモジュレーターを含んで成る併用療法 |
| WO2007049050A2 (en) * | 2005-10-27 | 2007-05-03 | Heptahelix Ab | Modulators of gpr40 for the treatment of diabetes |
| NZ587094A (en) | 2008-02-04 | 2011-07-29 | Pfizer Ltd | Polymorphic form of a [1, 2, 4] triazolo [4, 3-a] pyridine derivative for treating inflammatory diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5594016A (en) * | 1992-12-28 | 1997-01-14 | Mitsubishi Chemical Corporation | Naphthalene derivatives |
| JP2845743B2 (ja) | 1992-12-28 | 1999-01-13 | 三菱化学株式会社 | 新規なナフタレン誘導体 |
| JP4023697B2 (ja) | 1996-11-14 | 2007-12-19 | 三菱化学株式会社 | ナフタレン誘導体の製造方法 |
| PT1131310E (pt) * | 1998-11-20 | 2006-05-31 | Mitsubishi Chem Corp | Cristais de 5-[{6-(2-fluorobenzil)oxi-2-naftil}metil]-2,4-tiazolidinadiona |
-
1999
- 1999-11-19 PT PT99972628T patent/PT1131310E/pt unknown
- 1999-11-19 CA CA002351727A patent/CA2351727C/en not_active Expired - Fee Related
- 1999-11-19 TR TR2001/01901T patent/TR200101901T2/xx unknown
- 1999-11-19 IL IL14317799A patent/IL143177A0/xx unknown
- 1999-11-19 NZ NZ512429A patent/NZ512429A/en unknown
- 1999-11-19 KR KR1020017006299A patent/KR100652326B1/ko not_active IP Right Cessation
- 1999-11-19 ID IDW00200101331A patent/ID30064A/id unknown
- 1999-11-19 CZ CZ20011763A patent/CZ20011763A3/cs unknown
- 1999-11-19 AT AT99972628T patent/ATE315552T1/de not_active IP Right Cessation
- 1999-11-19 US US09/856,295 patent/US6541493B1/en not_active Expired - Fee Related
- 1999-11-19 TR TR2002/02103T patent/TR200202103T2/xx unknown
- 1999-11-19 HU HU0104139A patent/HUP0104139A3/hu unknown
- 1999-11-19 JP JP2000583883A patent/JP3784001B2/ja not_active Expired - Fee Related
- 1999-11-19 TR TR2002/02109T patent/TR200202109T2/xx unknown
- 1999-11-19 DE DE69929476T patent/DE69929476T2/de not_active Expired - Fee Related
- 1999-11-19 BR BR9916795-6A patent/BR9916795A/pt not_active IP Right Cessation
- 1999-11-19 PL PL99348502A patent/PL348502A1/xx unknown
- 1999-11-19 EP EP99972628A patent/EP1131310B1/en not_active Expired - Lifetime
- 1999-11-19 WO PCT/JP1999/006492 patent/WO2000031055A1/en active IP Right Grant
- 1999-11-19 TR TR2002/02110T patent/TR200202110T2/xx unknown
- 1999-11-19 ES ES99972628T patent/ES2257104T3/es not_active Expired - Lifetime
- 1999-11-19 AU AU11851/00A patent/AU1185100A/en not_active Abandoned
- 1999-11-19 CN CN99813380A patent/CN1326449A/zh active Pending
- 1999-11-20 TW TW088120305A patent/TWI250156B/zh not_active IP Right Cessation
- 1999-11-20 TW TW094136910A patent/TWI272944B/zh not_active IP Right Cessation
-
2001
- 2001-05-18 NO NO20012444A patent/NO20012444L/no not_active Application Discontinuation
- 2001-05-18 ZA ZA200104081A patent/ZA200104081B/en unknown
-
2003
- 2003-01-31 US US10/355,160 patent/US20030158241A1/en not_active Abandoned
-
2006
- 2006-02-21 US US11/357,208 patent/US20060149075A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69915223D1 (de) | Neue heterocyclische analoge von diphenylethylenverbindungen | |
| PT68915A (de) | Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide verfahren zu ihrer herstellung ihre verwendung und dieseverbindungen enthaltend arzneimittel | |
| IL181298A0 (en) | Solid and crystalline ibandronate sodium and processes for preparation thereof | |
| DE59409322D1 (de) | Essigsäurederivate als Arzneimittel | |
| ATE35827T1 (de) | Menschliches lymphotoxin und seine derivate, verfahren zu seiner herstellung und dasselbe enthaltende pharmazeutische zusammensetzungen. | |
| BR9913681A (pt) | Composição farmacêutica compreendendo entacapona ou nitecapona, assim como um derivado de celulose reticulada | |
| FI882912A (fi) | Laekemedelspreparat med finfoerdelade ebselen-kristaller. | |
| BR9916795A (pt) | Cristais de 5-{{6-( 2-fluorobenzil) oxi-2- naftil} metil} -2,4- tiazolidinodiona | |
| DK324185A (da) | 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf | |
| EA200000655A1 (ru) | Гидрат соли малеиновой кислоты 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона | |
| DK1360178T3 (da) | Hidtil ukendte heterocykliske analoger af diphenylethylenforbindelser | |
| JPS55113723A (en) | Drug composition to be absorbed in digestive canal | |
| ATE164374T1 (de) | Thiazolidin-2,4-dion-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten | |
| IL67564A0 (en) | (1,2)-fused 1,4-benzodiazepine compounds,their preparation and pharmaceutical compositions containing them | |
| ES531447A0 (es) | Procedimiento de preparar derivados de n-cicloalcoilmetil-2 oxo-3 diaril 5-6 as triacina | |
| JPS57206683A (en) | Pyrimidone salt, manufacture and medicinal composition containing same | |
| JPS5430081A (en) | Thermocouple thermometer | |
| ES8302006A1 (es) | Procedimiento para la preparacion de nuevas cefalosporinas . | |
| Evans et al. | Characterization and organization of the matrix of chiton teeth | |
| Kawamura et al. | STUDY ON THE VITRIFICATION PROCESS OF KAOLIN-LIMESTONE MIXTURES | |
| JPS53147745A (en) | Mold forming film | |
| ECSP951532A (es) | Eteres substituidos con tiazol y oxazol biciclicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |